AstraZeneca · 23 hours ago
Senior Scientist, Immunology Cell Therapy Discovery
AstraZeneca is a science-led biopharmaceutical company focused on transforming patient outcomes. They are seeking a Senior Scientist to advance novel cell therapies for autoimmune and other immunology indications, leading in vitro functional assays and collaborating with cross-functional teams to drive project planning and delivery.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Lead cell therapy target validation and characterize activity of engineered cell therapies using human primary cells and functional co-culture assays; develop and optimize assays; preferred flexibility to additionally contribute to in vivo study design and execution in partnership with in vivo pharmacology
Apply a rigorous, data-driven approach to experimental design, mechanism-of-action studies, and decision-making; use appropriate analytics and visualization; document work to high standards
Drive alignment with other teams including protein engineering, genomics, translational science, clinical, and CMC; translate scientific plans into clear objectives, risks, and decision points for clear communication across groups and to leadership
Collaborate to build and maintain project plans and timelines; manage dependencies and track progress to milestones
Present results and recommendations to teams and leadership; mentor colleagues and foster a productive lab environment
Qualification
Required
Education: PhD in immunology, cell biology, or related field with 0-5 years experience; or BS or MS with 10+ years of experience in a related field (industry experience strongly preferred)
In vitro expertise: Primary human cell culture and functional cell-based assays; multi‑color flow cytometry; multiplex cytokine detection; assay development
Extensive autoimmunity and/or inflammation experience: Familiarity with in vitro and in vivo model systems for conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease, COPD, fibrosis, etc
Data proficiency: Strong experimental design, analysis, and interpretation; proficiency with tools such as FlowJo and Prism
Communication: Proven ability to communicate complex scientific concepts clearly to technical and non-technical stakeholders
Leadership and collaboration: Strong drive for discovery, scientific curiosity, collaborative mindset; ability to mentor and influence across teams
Preferred
Cell therapy experience: Work with engineered cell products (e.g., T cell subsets, CAR-based modalities); familiarity with novel CAR or antibody target discovery
In vivo expertise: Hands-on planning, oversight, and execution of murine in vivo studies using autoimmune disease models; animal handling; standard dosing and engraftment; analysis of pharmacodynamic, immunophenotyping, and efficacy endpoints
Advanced analytics: Experience integrating complex datasets to guide decisions
Benefits
Short-term incentive bonus opportunity
Eligibility to participate in our equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
H1B Sponsorship
AstraZeneca has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (2)
2020 (11)
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Recent News
2026-01-09
2026-01-09
2026-01-09
Company data provided by crunchbase